As of 22 Sept 2026, Lotus Eye Hospital & Institute Ltd share price is ₹115.50. The stock opened at ₹115.50 and had closed at ₹112.65 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹97.60 and a high of ₹153.00. In terms of performance, Lotus Eye Hospital & Institute Ltd share price has increased by 5.96% over the past six months and has decreased by 4.23% over the last year.
LOTUSEYE Stock Price Chart
Lotus Eye Hospital & Institute Ltd Overview
About LOTUSEYE
Lotus Eye Hospital & Institute is engaged in the business of health care activities - Eye Care related sales and services.
Lotus Eye Hospital & Institute Ltd Historical Performance
Lotus Eye Hospital & Institute Ltd Fundamentals
Lotus Eye Hospital & Institute Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 54.89 | 50.86 | 49.51 | 48.19 | 39.80 |
| EBITDA | 4.56 | 4.75 | 7.84 | 8.73 | 6.72 |
| Net Profit | 0.08 | 0.74 | 2.91 | 4.08 | 2.98 |
| EPS | 0.04 | 0.36 | 1.40 | 1.96 | 1.44 |
Lotus Eye Hospital & Institute Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 112.62 |
| Resistance 1 (R1) | 112.67 |
| Pivot Point | 112.63 |
Lotus Eye Hospital & Institute Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 18-Sep-2023 | 24-May-2023 | 18-Sep-2023 | Final | ₹0.50 |
| 08-Sep-2022 | 25-May-2022 | 10-Sep-2022 | Final | ₹0.50 |
| 08-Sep-2021 | 02-Jul-2021 | 11-Sep-2021 | Final | ₹0.50 |
LOTUSEYE Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Sangeetha Sundaramoorthy | Managing Director |
| Kaveetha Sundaramoorthy | Chairman |
| K.S. Ramalingam | Chief Executive Officer |
Lotus Eye Hospital & Institute Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,933.50+0.24% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,058.20-0.79% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹895.70+0.25% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Lotus Eye Hospital & Institute Ltd today is ₹115.50 on NSE and ₹115.50 on BSE.
- The 52-week high of Lotus Eye Hospital & Institute Ltd is ₹153.00, while the 52-week low is ₹97.60.
- The current market capitalisation of Lotus Eye Hospital & Institute Ltd is approximately ₹240 crore.
- The P/E (Price-to-Earnings) ratio of Lotus Eye Hospital & Institute Ltd is 1650.00. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Lotus Eye Hospital & Institute Ltd is 3.99. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Lotus Eye Hospital & Institute Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for LOTUSEYE on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Lotus Eye Hospital & Institute Ltd has delivered a return of approximately 39.22%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Lotus Eye Hospital & Institute Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 40.14% promoters, 0.00% FIIs, 0.02% DIIs, and 36.43% public shareholders.

